Erste Asset Management GmbH Has $15.31 Million Position in Agilent Technologies, Inc. $A

Erste Asset Management GmbH raised its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 3.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 119,272 shares of the medical research company’s stock after purchasing an additional 4,210 shares during the quarter. Erste Asset Management GmbH’s holdings in Agilent Technologies were worth $15,309,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. Resona Asset Management Co. Ltd. lifted its position in shares of Agilent Technologies by 6.2% during the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock worth $11,631,000 after buying an additional 5,767 shares in the last quarter. CCLA Investment Management grew its holdings in shares of Agilent Technologies by 10.5% in the third quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock valued at $131,909,000 after acquiring an additional 97,312 shares in the last quarter. Envestnet Asset Management Inc. increased its position in shares of Agilent Technologies by 3.8% during the third quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock valued at $78,026,000 after acquiring an additional 22,498 shares during the last quarter. Nuance Investments LLC lifted its holdings in Agilent Technologies by 13.5% during the second quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after acquiring an additional 9,628 shares during the period. Finally, Osaic Holdings Inc. boosted its position in Agilent Technologies by 35.5% in the second quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock worth $8,017,000 after purchasing an additional 17,817 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. UBS Group decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday. Citigroup increased their price target on shares of Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. TD Cowen decreased their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Finally, JPMorgan Chase & Co. increased their target price on shares of Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $161.29.

Agilent Technologies Price Performance

NYSE A opened at $121.08 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. The company has a market cap of $34.25 billion, a PE ratio of 26.73, a price-to-earnings-growth ratio of 3.51 and a beta of 1.30. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The firm’s 50-day simple moving average is $134.67 and its two-hundred day simple moving average is $135.91.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). The business had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a return on equity of 24.95% and a net margin of 18.26%.Agilent Technologies’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s payout ratio is presently 22.52%.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Management raised FY‑2026 revenue ambition to $7.3B–$7.5B and highlighted expansion of its Ignite operating system as a path to future margin improvement. Read More.
• Positive Sentiment: Most sell‑side firms remain constructive (buy/overweight) and retain multi‑quarter price targets well above the current level despite trimming targets this week — supporting medium‑term upside if growth/margins recover. Read More.
• Neutral Sentiment: Agilent issued Q2 FY2026 EPS guidance of $1.39–1.42 and FY EPS of $5.90–6.04, which sits roughly around Street expectations — guidance is not a major beat or miss. Read More.
• Neutral Sentiment: Q4/CY2025 results were reported in line with expectations earlier, so the current reaction is focused on Q1 specifics and forward execution rather than a broader trend break. Read More.
• Negative Sentiment: Q1 results narrowly missed: EPS $1.36 vs. $1.37 consensus and revenue ~$1.80B vs. ~$1.81–1.84B estimates — the miss (and a weak margin cadence) triggered a near‑term selloff in earnings reaction. Read More.
• Negative Sentiment: Management said a severe U.S. winter storm disrupted shipments and service in the quarter, pressuring near‑term revenue and gross margins — investors may see this as a risk to near‑term execution. Read More.
• Negative Sentiment: Operating profit and operating cash flow declined year‑over‑year (cash from operations down notably), which raises short‑term concerns about margin leverage and free‑cash‑flow conversion. Institutional trimming noted in recent filings adds to near‑term selling pressure. Read More.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.